Bohan Ma
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 4
- Melanoma and MAPK Pathways 3
- Advanced biosensing and bioanalysis techniques 3
- Oncology 12
- Peptidase Inhibition and Analysis 8
- Co-authors
- Yongping Shao (8 shared papers)Wangxiao He (6 shared papers)Wuyuan Lu (6 shared papers)F. Niu (7 shared papers)Jin Yan (4 shared papers)X. Peter (3 shared papers)Lei Li (10 shared papers)Penghui Zhang (3 shared papers)
- Journals
- Advanced Science (3 papers)International Journal of Biological Macromolecules (3 papers)Nature Communications (2 papers)Advanced Materials (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bohan Ma
42 papers receiving 983 citations
Peers
Comparison fields: 5 of 93
- Biomaterials 182
- Molecular Biology 543
- Microbiology 47
- Oncology 177
- Biomedical Engineering 243
Countries citing papers authored by Bohan Ma
This map shows the geographic impact of Bohan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bohan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bohan Ma more than expected).
Fields of papers citing papers by Bohan Ma
This network shows the impact of papers produced by Bohan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bohan Ma. The network helps show where Bohan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bohan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 123 | |
| 2 | 2017 | 114 | |
| 3 | 2018 | 68 | |
| 4 | 2017 | 65 | |
| 5 | 2022 | 65 | |
| 6 | 2021 | 62 | |
| 7 | 2018 | 44 | |
| 8 | 2022 | 42 | |
| 9 | 2019 | 37 | |
| 10 | 2011 | 30 | |
| 11 | 2022 | 28 | |
| 12 | 2019 | 28 | |
| 13 | 2022 | 27 | |
| 14 | 2024 | 24 | |
| 15 | 2018 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2024 | 21 | |
| 18 | 2022 | 20 | |
| 19 | 2019 | 16 | |
| 20 | 2024 | 16 |
About Bohan Ma
Bohan Ma is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Food Science and Plant Science, having authored 45 papers that have together received 991 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (8 papers), Nanoplatforms for cancer theranostics (5 papers), Ubiquitin and proteasome pathways (4 papers), Melanoma and MAPK Pathways (3 papers), Multiple Myeloma Research and Treatments (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Biomaterials (182 citations), Molecular Biology (543 citations), Microbiology (47 citations), Oncology (177 citations) and Biomedical Engineering (243 citations). Bohan Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yongping Shao, Wangxiao He, Wuyuan Lu, F. Niu, Jin Yan, X. Peter, Lei Li, Penghui Zhang, Yaping Du and Yizeng Fan. Their work appears in journals such as Advanced Science, International Journal of Biological Macromolecules, Nature Communications, Advanced Materials and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.